Publicaciones en las que colabora con Ángel Pazos Carro (25)

2018

  1. Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders

    Biochemical Pharmacology, Vol. 157, pp. 258-265

  2. The endocannabinoid system in mental disorders: Evidence from human brain studies

    Biochemical Pharmacology, Vol. 157, pp. 97-107

2017

  1. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain

    Neuropharmacology, Vol. 114, pp. 114

2015

  1. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects

    Addiction Biology, Vol. 20, Núm. 4, pp. 773-783

2014

  1. Galanin activated Gi/o-proteins in human and rat central nervous systems

    Neuropeptides, Vol. 48, Núm. 5, pp. 295-304

2013

  1. Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

    Translational psychiatry, Vol. 3

2010

  1. α2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims

    Biological Psychiatry, Vol. 68, Núm. 9, pp. 869-872

2008

  1. Gene expression patterns in brain cortex of three different animal models of depression

    Genes, Brain and Behavior, Vol. 7, Núm. 6, pp. 649-658

2006

  1. Cannabinoid system in the budgerigar brain

    Brain Research, Vol. 1087, Núm. 1, pp. 105-113

  2. Transmembrane signaling through phospholipase C-β in the developing human prefrontal cortex

    Journal of Neuroscience Research, Vol. 84, Núm. 1, pp. 13-26

2005

  1. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties

    Psychopharmacology, Vol. 182, Núm. 3, pp. 400-413

2002

  1. Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis

    Synapse, Vol. 45, Núm. 4, pp. 245-249

2000

  1. Autoradiography of receptor-activated G-proteins in post mortem human brain

    Neuroscience, Vol. 96, Núm. 1, pp. 169-180

1998

  1. Selective increase of α(2A)-adrenoceptor agonist binding sites in brains of depressed suicide victims

    Journal of Neurochemistry, Vol. 70, Núm. 3, pp. 1114-1123

1997

  1. 125I-galanin binding sites in Alzheimer's disease: Increases in hippocampal subfields and a decrease in the caudate nucleus

    Journal of Neurochemistry, Vol. 68, Núm. 3, pp. 1106-1113

  2. Autoradiographic distribution of M1, M2, M3, and m4 muscarinic receptor subtypes in Alzheimer's disease

    Synapse, Vol. 26, Núm. 4, pp. 341-350

1996

  1. 2-Adrenoceptor subtypes in the human brain: A pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections

    European Journal of Pharmacology, Vol. 310, Núm. 1, pp. 83-93

  2. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization

    Neuroscience, Vol. 75, Núm. 3, pp. 901-915

  3. Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: An autoradiographic study in control and Alzheimer's disease brain tissues

    Brain Research, Vol. 728, Núm. 1, pp. 65-71

  4. The subtype-selective α2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT(1A) receptors in the rat brain

    European Journal of Pharmacology, Vol. 312, Núm. 3, pp. 385-388